Patterns of use and outcomes of adjuvant bevacizumab therapy prior to regulatory approval in women with newly diagnosed ovarian cancer.
Charlotte R GambleLing ChenElizabeth SzamretaMatthew MonbergDawn HershmanJason D WrightPublished in: Archives of gynecology and obstetrics (2022)
Real-world patterns of upfront bevacizumab use prior to FDA approval in 2018 differed significantly from trial data.